Federal Register / Vol. 79, No. 219 / Thursday, November 13, 2014 / Notices 67437 

ACTION: Notice. 

SUMMARY: This notice provides public 

announcement of CDC’s intent to award 

Ebola appropriations to the 

International Association of National 

Public Health Institutes (IANPHI) for 

response to the Ebola outbreak funding. 

This award was proposed in Fiscal Year 

(FY) 2015 under funding opportunity 

announcement GH14–1419 ‘‘Advancing 

National Public Health Institutes 

Globally’’. IANPHI is uniquely 

positioned, in terms of authority, ability, 

track record, infrastructure, and 

credibility to engage its member 

institutes to respond to the Ebola 

outbreak in West Africa. Furthermore, 

these activities to increase eligible 

governments’ capacity to respond to the 

Ebola outbreak are directly aligned with 

the current activities that IANPHI is 

conducting under this FOA to 

strengthen and expand national public 

health institute capabilities and support 

global health security. 

Catalogue of Federal Domestic Assistance 

Number (CFDA): 93.318. 

Authority: Sections 307 and 317(k)(2), 

Public Health Service Act 42 U.S.C. 242l and 

247b(k)(2) as amended. 

Single award may be awarded to 

grantee totaling $1,100,000 for Ebola 

response outbreak. 

Funding is appropriated under the 

Continuing Appropriations Resolution, 

2015, Public Law 113–164, 128 Stat. 

1867 (2014). 

DATES: Anticipated award date is 12/1/ 

2014. 

Application Due Date: 11/17/2014. 

Project Number is CDC–RFA–GH14– 

1419. 

ADDRESSES: CDC has waived the 

Grants.gov electronic submission 

process for this requirement. Recipients 

are hereby authorized to submit a paper 

copy application for (CDC–RFA–GH14– 

1419) via Express Mail (i.e. FedEx, UPS, 

or DHL) and send the application via 

email. Mailed applications must be 

address to Dionne Bounds, Centers for 

Disease Control and Prevention, 2920 

Brandywine Road, Atlanta, GA 30341, 

telephone (770) 488–2082, or email her 

at DBounds@cdc.gov. The application 

must include a detailed line-item budget 

and justification to support the Ebola 

activities from December 1, 2014 to 

September 29, 2015. 

Please download the following to 

complete the application package: 

http://apply07.grants.gov/apply/forms/

sample/SF424_2_1-V2.1.pdf— 

Application Package 

http://www.cdc.gov/od/pgo/funding/

docs/CertificationsForm.pdf— 

Certifications 

http://www.cdc.gov/od/pgo/funding/

grants/foamain.shtm—Assurances 

http://www.cdc.gov/od/pgo/funding/

grants/Budget_Preparation_

Guidelines_8-2-12.docx—CDC–PGO 

Budget Guidelines 

http://apply07.grants.gov/apply/forms/

sample/SF424A-V1.0.pdf—SF–424A 

Budget Information 

All applications must be submitted to 

and received by the Grants Management 

Officer (GMO) no later than 11:59 p.m. 

EST on November 17, 2014 and please 

provide the GMO a PDF version of the 

application by email to the following 

email address: ogsghsebolaresponse@

cdc.gov subject line: CDC–RFA–GH14– 

1419. 

Applicants will be provided with the 

Funding Opportunity Announcement 

(FOA) and additional application 

submission guidance via email 

notification. Applicants may contact the 

POCs listed with questions regarding 

the application process. 

FOR FURTHER INFORMATION CONTACT: 

For programmatic or technical 

assistance: Miranda Bodfish, Project 

Officer, Department of Health and 

Human Services, Centers for Disease 

Control and Prevention, 1600 Clifton 

Rd. MS E–93, Atlanta, GA 30333, 

Telephone: 404 719–0232, email: 

WTI4@cdc.gov. 

For financial, awards management, or 

budget assistance: Dionne Bounds, 

Grants Management Officer, Centers for 

Disease Control and Prevention, 2920 

Brandywine Road, Atlanta, GA 30341, 

Telephone (770) 488- 2082, email: 

DBounds@cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

purpose of this notice is to solicit an 

application from IANPHI to assist in the 

response to the Ebola virus in West 

Africa. The funding will support the 

impacted surrounding countries to 

combat this health crisis. This funding 

will target the following countries: 

Cameroon, Cote d’Ivoire, Guinea, and 

Guinea-Bissau to support the responses 

of the CDC to the outbreak of Ebola 

virus in West Africa. This funding will 

enable the U.S. to provide unified 

mobilization to address a crisis of this 

magnitude. CDC will continue to build 

partnerships and strengthen existing 

projects to respond to Ebola. CDC and 

its partners will help to address the 

need for surveillance, detection, 

coordination, response, and increase 

eligible governments’ capacity to 

respond to the Ebola outbreak. 

Award Information 

Type of Award: Expansion 

Supplement. 

Approximate Total Current Fiscal 

Year Funding: $1,100,000. 

Anticipated Number of Awards: One. 

Fiscal Year Funds: 2015. 

Anticipated Award Date: December 1, 

2014. 

Application Selection Process: 

Funding will be awarded to applicant 

based on results from the technical 

review recommendation. 

Dated: November 6, 2014. 

Ron A. Otten, 

Acting Deputy Associate Director for Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2014–26799 Filed 11–7–14; 11:15 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: Objective Work Plan (OWP) and 

Objective Progress Report (OPR). 

OMB No.: 0970–0429. 

Description: Content and formatting 

changes are being made to the OPR and 

OWP. The information in OPR is 

currently collected on quarterly basis to 

monitor the performance of grantees and 

better gauge grantee progress. The OWP 

is used by applicants when they submit 

their proposals and then by grantees to 

monitor their projects once the award is 

made by ANA. ANA has determined 

that the requirement for ANA grantees 

to submit information about the project 

activities on quarterly basis creates 

undue burden for Grantees. Therefore, 

ANA has reformatted the OPR to require 

Grantees submit semi-annual reports 

instead of quarterly report. This will 

reduce the administrative burden on 

Grantees, especially the smaller 

organizations. The majority of content 

being requested from the grantees 

essentially remain same except for the 

frequency of reporting. 

OPR: The following are proposed 

content changes to the document: 

Grantee Information: Report 

Frequency—This section of OPR will be 

reformatted to request semi-annual or 

final project data instead of quarterly 

information. The other sections of the 

document with reference to ‘‘quarterly’’ 

information will be changed to reflect 

the shift from four-times a year 

reporting requirement to twice per year. 

Objective Work Plan Update: Content 

remains the same. No changes are 

proposed for this section of the OPR. 

Impact indicator: Current Status of 

Expected Results and Current Status of 

Expected Benefits which are reported 

separately on the OPR will be combined 


tkelley on DSK3SPTVN1PROD with NOTICES
67438 Federal Register / Vol. 79, No. 219 / Thursday, November 13, 2014 / Notices 

to read ‘‘Current Status of Expected 

Results and Benefits.’’ The content 

requested in this section is similar to the 

previous OPR without the added burden 

of having the reporting organizations 

provide the analysis that distinguish 

between ‘‘results and benefits’’. Every 

section of the document will be 

rewritten to reflect this change. 

OWP: ANA proposes to reformat the 

OWP (content is same) by swapping the 

Objective field with Problem Statement. 

In other words, this section will require 

respondents to begin with a concise 

statement about the problem the project 

is designed to address and will be 

followed by more details about the 

objectives of the project. 

The two fields ‘‘Results Expected and 

Benefits Expected’’ will be combined 

into one field to read ‘‘Results and 

benefits Expected’’. This will reduce 

redundancy and help reduce the burden 

on Grantees. 

Respondents: Tribal Government, 

Native non-profit organizations, Tribal 

Colleges & Universities. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

OWP ................................................................................................................ 500 1 3 1,500 

OPR ................................................................................................................. 275 2 1 550

Estimated Total Annual Burden 

Hours: 2,050. 

Additional Information: Copies of the 

proposed collection may be obtained by 

writing to the Administration for 

Children and Families, Office of 

Planning, Research and Evaluation, 370 

L’Enfant Promenade SW., Washington, 

DC 20447, Attn: ACF Reports Clearance 

Officer. All requests should be 

identified by the title of the information 

collection. Email address: 

infocollection@acf.hhs.gov. 

OMB Comment: OMB is required to 

make a decision concerning the 

collection of information between 30 

and 60 days after publication of this 

document in the Federal Register. 

Therefore, a comment is best assured of 

having its full effect if OMB receives it 

within 30 days of publication. Written 

comments and recommendation for the 

proposed information collection should 

be sent directly to the following: Office 

of Management and Budget, Paperwork 

Reduction Project, Fax: 202–395–7285, 

Email: OIRA_SUBMISSION@

OMB.EOP.GOV, Attn: Desk Officer for 

the Administration for Children and 

families. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 2014–26785 Filed 11–12–14; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2014–N–0001] 

Science Board to the Food and Drug 

Administration Advisory Committee 

Meeting; Amendment of Notice 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing an 

amendment to the notice of meeting of 

the Science Board to the Food and Drug 

Administration. This meeting was 

announced in the Federal Register of 

October 8, 2014. The amendment is 

being made to reflect changes in URL for 

the Webcast. There are no other 

changes. 

FOR FURTHER INFORMATION CONTACT: 

Martha Monser, Office of the Chief 

Scientist, Food and Drug 

Administration, 10903 New Hampshire 

Ave., Bldg. 1, Rm. 3309, Silver Spring, 

MD 20993, 301–796–4627, or FDA 

Advisory Committee Information Line, 

1–800–741–8138 (301–443–0572 in the 

Washington, DC area). Please call the 

Information Line for up-to-date 

information on this meeting. 

SUPPLEMENTARY INFORMATION: In the 

Federal Register of October 8, 2014 (79 

FR 60856), FDA announced that a 

meeting of the Science Board to the 

Food and Drug Administration would 

be held on November 19 and 20, 2014. 

On page 60857, in the first column, the 

URL information is changed to read as 

follows: 

The link for the Webcast on 

November 19, 2014, is available at: 

https://collaboration.fda.gov/ 

scienceboard111914/. The link for the 

Webcast on November 20, 2014, is 

available at: https:// 

collaboration.fda.gov/scienceboard

112014. 

This notice is issued under the 

Federal Advisory Committee Act (5 

U.S.C. app. 2) and 21 CFR part 14, 

relating to the advisory committees. 

Dated: November 5, 2014. 

Jill Hartzler Warner, 

Associate Commissioner for Special Medical 

Programs. 

[FR Doc. 2014–26821 Filed 11–12–14; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2014–N–1732] 

Food Advisory Committee; Notice of 

Meeting; Amendment of Notice 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing an 

amendment to the notice of the meeting 

of the Food Advisory Committee. This 

meeting was announced in the Federal 

Register of August 19, 2014. The 

amendment is being made to add an 

ADDRESSES section and to reflect a 

change in the Agenda. There are no 

other changes. 

FOR FURTHER INFORMATION CONTACT: 

Karen Strambler, Center for Food Safety 

and Applied Nutrition, Food and Drug 

Administration, 5100 Paint Branch 

Pkwy., College Park, MD 20740, 240– 

402–2589, FAX: 301–436–2637, email: 

FoodAdvisoryCommittee@fda.hhs.gov, 

or FDA Advisory Committee 

Information Line, 1–800–741–8138 

(301–443–0572 in the Washington, DC 

area) and follow the prompts to the 

desired Center or product area. Please 

call the Information Line for up-to-date 

information on this meeting. 

SUPPLEMENTARY INFORMATION: In the 

Federal Register of August 19, 2014 (79 

FR 49091), FDA announced that a 

meeting of the Food Advisory 


tkelley on DSK3SPTVN1PROD with NOTICES